Vertex Pharmaceuticals
VRTX
#201
Rank
$114.62 B
Marketcap
$451.63
Share price
-1.60%
Change (1 day)
2.44%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total assets

Total assets on the balance sheet as of March 2026 : $26.48 Billion USD

According to Vertex Pharmaceuticals's latest financial reports the company's total assets are $26.48 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Vertex Pharmaceuticals - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31$25.64 B13.8%
2024-12-31$22.53 B-0.87%
2023-12-31$22.73 B25.23%
2022-12-31$18.15 B35.13%
2021-12-31$13.43 B14.3%
2020-12-31$11.75 B41.27%
2019-12-31$8.31 B33.18%
2018-12-31$6.24 B76.14%
2017-12-31$3.54 B22.41%
2016-12-31$2.89 B15.94%
2015-12-31$2.49 B7.02%
2014-12-31$2.33 B0.67%
2013-12-31$2.31 B-15.96%
2012-12-31$2.75 B25.18%
2011-12-31$2.20 B27.75%
2010-12-31$1.72 B-11.76%
2009-12-31$1.95 B99.44%
2008-12-31$0.98 B63.01%
2007-12-31$0.60 B-34.73%
2006-12-31$0.92 B67.87%
2005-12-31$0.54 B0.65%
2004-12-31$0.54 B-24.7%
2003-12-31$0.72 B-11.19%
2002-12-31$0.81 B-11.83%
2001-12-31$0.92 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
$200.89 B 658.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$136.46 B 415.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$56.27 B 112.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$128.68 B 385.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$86.47 B 226.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
$0.28 B-98.94%๐Ÿ‡บ๐Ÿ‡ธ USA